Mariner’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,566
Closed -$266K 3820
2026
Q1
$266K Sell
2,566
-673
-21% -$71.1K ﹤0.01% 2975
2025
Q4
$339K Buy
3,239
+497
+18% +$50K ﹤0.01% 2739
2025
Q3
$254K Buy
2,742
+1
+0% +$88 ﹤0.01% 2963
2025
Q2
$219K Sell
2,741
-513
-16% -$40.9K ﹤0.01% 2984
2025
Q1
$282K Buy
3,254
+2
+0.1% +$170 ﹤0.01% 2681
2024
Q4
$269K Buy
3,252
+3
+0.1% +$258 ﹤0.01% 2725
2024
Q3
$283K Buy
3,249
+256
+9% +$21.9K ﹤0.01% 2624
2024
Q2
$246K Sell
2,993
-3,055
-51% -$243K ﹤0.01% 2609
2024
Q1
$485K Buy
6,048
+2,594
+75% +$201K ﹤0.01% 2042
2023
Q4
$263K Buy
+3,454
New +$247K ﹤0.01% 2457
2023
Q3
Sell
-4,173
Closed -$316K 2995
2023
Q2
$316K Buy
4,173
+384
+10% +$29.3K ﹤0.01% 2078
2023
Q1
$288K Sell
3,789
-145
-4% -$11.2K ﹤0.01% 2104
2022
Q4
$309K Buy
3,934
+4
+0.1% +$307 ﹤0.01% 2008
2022
Q3
$280K Buy
+3,930
New +$293K ﹤0.01% 1821

Other funds holding PJP

Mariner's PJP Position: Q2 2026 in Review

Mariner sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2026, closing a stake of 2,566 shares — an estimated $266K sold.

Mariner first reported a position in PJP in Q3 2022 and held it in 14 quarters. The position peaked at $485K in Q1 2024. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • Mariner reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
  • Mariner sold 2,566 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $266K.
  • Mariner first reported a position in Invesco Pharmaceuticals ETF in Q3 2022 and held it in 14 quarters.
  • Mariner's Invesco Pharmaceuticals ETF position peaked at $485K in Q1 2024.
  • 117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.